ZNF529
gene geneOn this page
Also known as KIAA1615
Summary
ZNF529 (zinc finger protein 529, HGNC:29328) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 529 (Q6P280). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 57711 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 78 total
- MANE Select transcript:
NM_020951
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29328 |
| Approved symbol | ZNF529 |
| Name | zinc finger protein 529 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1615 |
| Ensembl gene | ENSG00000186020 |
| Ensembl biotype | protein_coding |
| Entrez | 57711 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 12 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000334116, ENST00000452073, ENST00000585960, ENST00000585983, ENST00000586115, ENST00000586458, ENST00000587286, ENST00000590656, ENST00000591340, ENST00000867184, ENST00000867185, ENST00000867186, ENST00000867187, ENST00000933095
RefSeq mRNA: 6 — MANE Select: NM_020951
NM_001145649, NM_001145650, NM_001321351, NM_001352272, NM_001352273, NM_020951
CCDS: CCDS54256, CCDS82335
Canonical transcript exons
ENST00000591340 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002749174 | 36573140 | 36573292 |
| ENSE00002890383 | 36543613 | 36548322 |
| ENSE00003466838 | 36554670 | 36554796 |
| ENSE00003497591 | 36572333 | 36572392 |
| ENSE00003623172 | 36556104 | 36556197 |
Expression profiles
Bgee: expression breadth ubiquitous, 277 present calls, max score 91.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.7339 / max 265.8441, expressed in 1776 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180682 | 9.7435 | 1744 |
| 180685 | 3.5542 | 1010 |
| 180684 | 0.2057 | 99 |
| 180683 | 0.1227 | 28 |
| 180686 | 0.1078 | 39 |
Top tissues by expression
292 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 91.64 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 90.12 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 89.43 | gold quality |
| oocyte | CL:0000023 | 89.26 | gold quality |
| cortical plate | UBERON:0005343 | 88.72 | gold quality |
| secondary oocyte | CL:0000655 | 88.58 | gold quality |
| buccal mucosa cell | CL:0002336 | 87.12 | silver quality |
| skin of hip | UBERON:0001554 | 86.87 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 85.83 | gold quality |
| upper leg skin | UBERON:0004262 | 85.79 | gold quality |
| right uterine tube | UBERON:0001302 | 85.76 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 85.61 | gold quality |
| cerebellar cortex | UBERON:0002129 | 85.54 | gold quality |
| adrenal tissue | UBERON:0018303 | 85.40 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 85.38 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 84.84 | gold quality |
| cerebellum | UBERON:0002037 | 84.77 | gold quality |
| primary visual cortex | UBERON:0002436 | 84.65 | gold quality |
| caput epididymis | UBERON:0004358 | 84.58 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.00 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.00 | gold quality |
| corpus callosum | UBERON:0002336 | 83.91 | gold quality |
| entorhinal cortex | UBERON:0002728 | 83.89 | gold quality |
| parietal pleura | UBERON:0002400 | 83.75 | gold quality |
| tibia | UBERON:0000979 | 83.69 | gold quality |
| spinal cord | UBERON:0002240 | 83.41 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.30 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.30 | gold quality |
| cauda epididymis | UBERON:0004360 | 83.17 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.88 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | yes | 11.29 |
| E-ANND-3 | yes | 4.82 |
| E-GEOD-75367 | no | 254.31 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
170 targeting ZNF529, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 529 — Q6P280 (reviewed: Q6P280)
All UniProt accessions (7): A0A0C4DFR4, Q6P280, K7EKM0, K7EL49, K7ELR0, K7ES80, K7ESA1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (6): NP_001139121, NP_001139122, NP_001308280, NP_001339201, NP_001339202, NP_066002* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (19 total): zinc finger region 12, cross-link 2, sequence conflict 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P280-F1 | 58.59 | 0.16 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 87, 268
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 125 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP, GCM_GSPT1, GCM_ZNF198, GCM_BCL2L1, GCM_SUFU, DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP, GCM_NF2, MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6, GCM_RBM8A, NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP, BROWNE_HCMV_INFECTION_48HR_UP, GCM_RAN, GCM_MLL
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), sequence-specific DNA binding (GO:0043565), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
538 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF529 | RSPH14 | Q9UHP6 | 580 |
| ZNF529 | SNX14 | Q9Y5W7 | 578 |
| ZNF529 | PNRC2 | Q9NPJ4 | 502 |
| ZNF529 | GARIN5A | Q6IPT2 | 477 |
| ZNF529 | SLC6A13 | Q9NSD5 | 470 |
| ZNF529 | NLE1 | Q9NVX2 | 466 |
| ZNF529 | KHDC4 | Q7Z7F0 | 450 |
| ZNF529 | LGALS4 | P56470 | 407 |
| ZNF529 | SRPRB | Q9Y5M8 | 406 |
| ZNF529 | MRPS12 | O15235 | 396 |
| ZNF529 | CLIP4 | Q8N3C7 | 380 |
| ZNF529 | WDR44 | Q5JSH3 | 377 |
| ZNF529 | GPLD1 | P80108 | 373 |
| ZNF529 | FOXC1 | Q12948 | 372 |
| ZNF529 | LIPC | P11150 | 368 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MYL2 | ZNF529 | psi-mi:“MI:0915”(physical association) | 0.490 |
BioGRID (9): ZNF529 (Biochemical Activity), ZNF529 (Two-hybrid), ZNF529 (Affinity Capture-MS), ZNF529 (Protein-peptide), ZNF529 (Affinity Capture-MS), ZNF529 (Affinity Capture-MS), ZNF529 (Cross-Linking-MS (XL-MS)), ZNF529 (Proximity Label-MS), ZNF529 (Affinity Capture-RNA)
ESM2 similar proteins: A0JPL0, A6NK53, E7ETH6, E9Q8G5, O14628, P21506, P51508, Q09FC8, Q13360, Q2M218, Q2M3X9, Q2VY69, Q3KQV3, Q3SY52, Q4R882, Q5HY98, Q5REN4, Q5RES8, Q68DI1, Q6NX49, Q6P280, Q6PG37, Q6V9R5, Q6ZMW2, Q7Z340, Q86XU0, Q8IYI8, Q8N587, Q8N720, Q8N859, Q8NB42, Q8NDW4, Q8NEK5, Q8WXB4, Q96MR9, Q96MU6, Q96NG8, Q96NJ3, Q96SR6, Q9BR84
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
78 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 69 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
920 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:36554665:TTTA:T | donor_loss | 1.0000 |
| 19:36554666:TTACC:T | donor_loss | 1.0000 |
| 19:36554667:TA:T | donor_loss | 1.0000 |
| 19:36554668:A:AC | donor_gain | 1.0000 |
| 19:36554668:A:C | donor_loss | 1.0000 |
| 19:36554668:AC:A | donor_gain | 1.0000 |
| 19:36554669:C:CC | donor_gain | 1.0000 |
| 19:36554669:CC:C | donor_gain | 1.0000 |
| 19:36554672:A:AC | donor_gain | 0.9900 |
| 19:36554709:C:A | donor_gain | 0.9900 |
| 19:36554792:AGTTC:A | acceptor_gain | 0.9900 |
| 19:36554793:GTTC:G | acceptor_gain | 0.9900 |
| 19:36554794:TTC:T | acceptor_gain | 0.9900 |
| 19:36554795:TC:T | acceptor_gain | 0.9900 |
| 19:36554796:CC:C | acceptor_gain | 0.9900 |
| 19:36554797:C:CC | acceptor_gain | 0.9900 |
| 19:36554797:CTGAA:C | acceptor_loss | 0.9900 |
| 19:36554798:T:A | acceptor_loss | 0.9900 |
| 19:36572393:C:CC | acceptor_gain | 0.9900 |
| 19:36572403:A:T | acceptor_gain | 0.9900 |
| 19:36548319:AAATC:A | acceptor_loss | 0.9800 |
| 19:36548322:TC:T | acceptor_loss | 0.9800 |
| 19:36548323:C:CA | acceptor_loss | 0.9800 |
| 19:36548324:T:A | acceptor_loss | 0.9800 |
| 19:36551868:T:C | donor_gain | 0.9800 |
| 19:36554708:T:TA | donor_gain | 0.9800 |
| 19:36556102:A:AC | donor_gain | 0.9800 |
| 19:36556103:C:CC | donor_gain | 0.9800 |
| 19:36572402:C:CT | acceptor_gain | 0.9800 |
| 19:36548323:C:CC | acceptor_gain | 0.9700 |
AlphaMissense
3802 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:36547265:A:C | F431L | 0.998 |
| 19:36547265:A:T | F431L | 0.998 |
| 19:36547267:A:G | F431L | 0.998 |
| 19:36547517:A:C | F347L | 0.998 |
| 19:36547517:A:T | F347L | 0.998 |
| 19:36547519:A:G | F347L | 0.998 |
| 19:36547601:G:C | F319L | 0.998 |
| 19:36547601:G:T | F319L | 0.998 |
| 19:36547603:A:G | F319L | 0.998 |
| 19:36547097:A:C | F487L | 0.997 |
| 19:36547097:A:T | F487L | 0.997 |
| 19:36547099:A:G | F487L | 0.997 |
| 19:36547332:A:G | L409P | 0.997 |
| 19:36547349:A:C | F403L | 0.997 |
| 19:36547349:A:T | F403L | 0.997 |
| 19:36547351:A:G | F403L | 0.997 |
| 19:36547433:A:C | F375L | 0.997 |
| 19:36547433:A:T | F375L | 0.997 |
| 19:36547435:A:G | F375L | 0.997 |
| 19:36547584:A:G | L325P | 0.997 |
| 19:36547408:G:C | H384D | 0.996 |
| 19:36547500:A:G | L353P | 0.996 |
| 19:36547572:T:G | Q329P | 0.996 |
| 19:36554762:A:G | F48S | 0.996 |
| 19:36547154:A:C | H468Q | 0.995 |
| 19:36547154:A:T | H468Q | 0.995 |
| 19:36547322:A:C | H412Q | 0.995 |
| 19:36547322:A:T | H412Q | 0.995 |
| 19:36547324:G:C | H412D | 0.995 |
| 19:36547336:A:G | S408P | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000027576 (19:36583680 GA>G,GAA), RS1000059156 (19:36595215 A>C,G), RS1000156644 (19:36589737 G>C), RS1000165260 (19:36602441 T>A,C), RS1000184058 (19:36555034 T>C), RS1000184853 (19:36606121 T>G), RS1000237346 (19:36605881 T>C), RS1000263490 (19:36548747 G>A), RS1000334977 (19:36581828 G>A), RS1000364544 (19:36570486 A>G), RS1000367485 (19:36598944 C>G,T), RS1000500302 (19:36591490 C>T), RS1000543165 (19:36553165 G>A), RS1000606742 (19:36555657 T>C), RS1000687488 (19:36561033 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST011347_60 | Low density lipoprotein cholesterol levels | 1.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004611 | low density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases expression | 6 |
| trichostatin A | affects cotreatment, decreases expression, increases expression | 3 |
| mercuric bromide | decreases expression, affects cotreatment | 2 |
| Air Pollutants | increases abundance, increases expression, decreases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Particulate Matter | increases abundance, increases expression, decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| resorcinol | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| K 7174 | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | increases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| Temozolomide | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Naled | affects expression | 1 |
| Urethane | affects expression | 1 |
| Cyclosporine | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW59 | HEK293 eGFP-ZNF529 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.